The CAPTURE Study: Validating a unique COPD screening tool in primary care
The CAPTURE Study: Validating a unique COPD screening tool in primary care
批准号:
10197199
负责人:
MeiLan K Han
金额:
$198.36万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-01 至 2024-06-30
关键词:
AcuteAddressAdvocateAmbulatory CareCaringCharacteristicsChronic Obstructive Airway DiseaseClinicClinicalClinical TrialsCohort StudiesDataDeteriorationDiagnosticEducationExhibitsFocus GroupsGenderGoalsGoldGuidelinesHealthHealth PersonnelHealth StatusHealthcare SystemsHuman ResourcesImpaired healthIndividualKnowledgeLabelLogicLung diseasesMeasurementMethodologyMissionModelingMorbidity - disease rateOnline SystemsOutcomePatient CarePatientsPeak Expiratory FlowPopulationPredictive ValuePrimary Health CareProcessPublic HealthPulmonary Function Test/Forced Expiratory Volume 1QuestionnairesReach, Effectiveness, Adoption, Implementation, and MaintenanceRecommendationResearchRiskScreening procedureSelf EfficacySensitivity and SpecificitySeveritiesSiteSpirometrySurveysTelephoneTestingTherapeuticUnited StatesUnited States National Institutes of HealthWorkbasecase findingclinical careclinical practiceclinical translationclinically relevantclinically significantdisease diagnosisexperiencehealth care service utilizationimprovedinnovationmortalitynovelpatient populationpatient subsetsprimary care settingprospectiveprovider behaviorrespiratoryscreeningsocioeconomicstool
中文摘要
项目总结/文摘
英文摘要
PROJECT SUMMARY/ABSTRACT
Most COPD patients remain unrecognized and undertreated; these individuals experience impaired health
status, acute respiratory deteriorations, increased mortality and high health care utilization. Targeted case finding
to date has generally identified patients without reference to spirometric severity or exacerbation (ECOPD) risk.
We have developed a simple case finding tool using five questions combined with selective peak expiratory flow
measurement (CAPTURE) that identifies individuals with “clinically significant COPD,” those most likely to benefit
from currently available therapies. Our long-term goal is to effectively identify these individuals so therapy can
improve health status, reduce ECOPD, and decrease morbidity. The overall objectives of this proposal are to
validate the sensitivity, specificity, and predictive value of CAPTURE to identify undiagnosed, clinically significant
COPD in a diverse primary care population; to confirm that this methodological approach can be integrated into
a variety of primary clinical care settings; and explore whether identifying these patients results in improved
COPD specific care and health status. Our central hypothesis is that CAPTURE can effectively and efficiently
identify primary care patients with undiagnosed, clinically significant COPD. The rationale for the proposed
research is that the answer to three simple questions will change the paradigm for COPD diagnosis in primary
care: 1) Is CAPTURE effective in identifying patients with clinically significant COPD; 2) Does CAPTURE work
in primary care settings; and 3) does CAPTURE make a difference in the lives of patients with previously
undiagnosed, clinically significant COPD. Guided by strong preliminary data we will pursue three specific aims:
1) We will determine the sensitivity and specificity of CAPTURE in identifying clinically significant COPD in a
broad range of primary care outpatient practices; 2) We will define the feasibility of using CAPTURE in 10
practices representing a wide range of primary care clinical settings across the US; 3) We will explore the impact
of our case finding approach in a broad range of primary care outpatient practices and evaluate practice and
patient level characteristics that are associated with COPD related care implementation and clinical outcomes.
These aims will be accomplished in a 5,000 subject cohort study in 75 primary care practices affiliated with five
primary care based research networks that provide access to previously undiagnosed patients who exhibit
ethnic, racial, socioeconomic and regional diversity. In a subset of these clinical practices we will complete a
detailed feasibility analysis of CAPTURE implementation. Our approach is highly innovative and clinically
relevant as it applies a rigorously developed, novel COPD case finding approach to identifying COPD patients
most likely to benefit from available therapy. The proposed research is significant, as the results will change the
paradigm for COPD diagnosis in primary care and change COPD recommendations globally.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Protocol Summary of the COPD Assessment in Primary Care To Identify Undiagnosed Respiratory Disease and Exacerbation Risk (CAPTURE) Validation in Primary Care Study.
初级保健中慢性阻塞性肺病评估的方案摘要,以确定初级保健研究中未确诊的呼吸道疾病和恶化风险 (CAPTURE) 验证。
DOI:
10.15326/jcopdf.2020.0155
发表时间:
2021
期刊:
Chronic obstructive pulmonary diseases (Miami, Fla.)
影响因子:
--
作者:
[Yawn,BarbaraP, Han,Meilan, Make,BarryM, Mannino,David, Brown,RandallW, Meldrum,Catherine, Murray,Susan, Spino,Cathie, Bronicki,JacquelineS, Leidy,Nancy, Tapp,Hazel, Dolor,RowenaJ, Joo,Min, Knox,Lyndee, Zittleman,Linda, Thomashow,Byron]
通讯作者:
Thomashow,Byron
Reply to Londhe et al.: CAPTURE: A Screening Tool for Chronic Obstructive Pulmonary Disease or Obstructive Airway Disease?
回复 Londhe 等人:CAPTURE:慢性阻塞性肺病或阻塞性气道疾病的筛查工具?
DOI:
10.1164/rccm.201707-1393le
发表时间:
2018
期刊:
American journal of respiratory and critical care medicine
影响因子:
24.7
作者:
[Martinez,FernandoJ, Han,MeiLan, Leidy,Nancy, Make,Barry, Mannino,DavidM, Rennard,StephenI, Thomashow,ByronM, Yawn,BarbaraP, High-Risk-COPDScreeningStudyGroup]
通讯作者:
High-Risk-COPDScreeningStudyGroup
Defining Pathways in COPD Patient Oriented Research
-
批准号:10198016
-
项目类别:
-
资助金额:$11.9万
-
财政年份:2017
-
负责人:MeiLan K Han
-
依托单位:
The CAPTURE Study: Validating a unique COPD screening tool in primary care
-
批准号:9981799
-
项目类别:
-
资助金额:$205.69万
-
财政年份:2017
-
负责人:MeiLan K Han
-
依托单位:
Defining Pathways in COPD Patient Oriented Research
-
批准号:9369171
-
项目类别:
-
资助金额:$11.9万
-
财政年份:2017
-
负责人:MeiLan K Han
-
依托单位:
Defining Pathways in COPD Patient Oriented Research
-
批准号:9975212
-
项目类别:
-
资助金额:$11.9万
-
财政年份:2017
-
负责人:MeiLan K Han
-
依托单位:
Defining Pathways in COPD Patient Oriented Research
-
批准号:10368585
-
项目类别:
-
资助金额:$12.28万
-
财政年份:2017
-
负责人:MeiLan K Han
-
依托单位:
Defining Pathways in COPD Patient Oriented Research
-
批准号:10674684
-
项目类别:
-
资助金额:$12.28万
-
财政年份:2017
-
负责人:MeiLan K Han
-
依托单位:
Redefining Therapy In Early COPD: RETHINC
-
批准号:9143794
-
项目类别:
-
资助金额:$34.12万
-
财政年份:2015
-
负责人:MeiLan K Han
-
依托单位:
Redefining Therapy In Early COPD: RETHINC
-
批准号:8955832
-
项目类别:
-
资助金额:$36.35万
-
财政年份:2015
-
负责人:MeiLan K Han
-
依托单位:
Beneficial effects of quercetin in COPD - a preliminary clinical trial
-
批准号:8542760
-
项目类别:
-
资助金额:$22.63万
-
财政年份:2012
-
负责人:MeiLan K Han
-
依托单位:
Impact of Gender on Symptoms and Progression of IPF
-
批准号:8067777
-
项目类别:
-
资助金额:$12.66万
-
财政年份:2009
-
负责人:MeiLan K Han
-
依托单位:
Impact of Gender on Symptoms and Progression of IPF
-
批准号:8261366
-
项目类别:
-
资助金额:$12.62万
-
财政年份:2009
-
负责人:MeiLan K Han
-
依托单位:
Impact of Gender on Symptoms and Progression of IPF
-
批准号:8463023
-
项目类别:
-
资助金额:$5.52万
-
财政年份:2009
-
负责人:MeiLan K Han
-
依托单位:
Impact of Gender on Symptoms and Progression of IPF
-
批准号:7661811
-
项目类别:
-
资助金额:$12.11万
-
财政年份:2009
-
负责人:MeiLan K Han
-
依托单位:
Impact of Gender on Symptoms and Progression of IPF
-
批准号:7817013
-
项目类别:
-
资助金额:$12.37万
-
财政年份:2009
-
负责人:MeiLan K Han
-
依托单位:
海外基金